Centro Médico Teknon
Centro Médico Teknon
Spain, Barcelona
Joan Carles Galceran
39 years of experience • 1200+ treatments performed
Clinic is certified :
Immunotherapy for prostate cancer in Spain typically costs from $35,000 to $65,000. The final price depends on the specific drug type, treatment duration, and required cycles. Patients save around 51% compared to the US, where this procedure costs $102,500 on average. Standard Spanish protocols usually include initial specialist consultations, drug administration, and routine monitoring during the therapy. Barcelona and Madrid remain the primary medical hubs for these advanced oncological treatments.
Bookimed Expert Insight: Spain offers a unique balance of high-tier clinical care and lower medication premiums. Centro Médico Teknon in Barcelona is a Joint Commission International (JCI) accredited facility with 400 specialized doctors. It is often chosen by high-profile international figures for its discretion and 5-star service. Hospital HM Nou Delfos provides access to one of the largest medical networks in Spain. Patients can access advanced radiotherapy units and urological expertise at competitive European rates. Choosing these established centers often secures better inclusive pricing for integrated diagnostic and treatment packages.
Why choose Spain for immunotherapy for prostate cancer?
Access advanced Immunotherapy for prostate cancer solutions in trusted clinics .
| Turkey | Austria | Spain | |
| Immunotherapy for prostate cancer | from $12,000 | from $30,000 | from $35,000 |
Day 1
Day 2
Day 3
Day 4
Week 1
Week 2
Week 3
Week 4
Please note that each patient"s experience with Immunotherapy for prostate cancer can vary. The above timeline provides a general guideline but individual cases may differ.
The doctor is a distinguished medical oncologist with over 30 years of experience, specializing in the non-surgical treatment of genitourinary cancers, including prostate, kidney, and bladder cancers, as well as sarcomas and tumors of unknown origin. Currently, the doctor leads the Genitourinary, Central Nervous System, Sarcoma, and Unknown Origin Tumors Unit at Vall d'Hebron University Hospital in Barcelona and is affiliated with the Teknon Medical Center.
With a Ph.D. in Medicine and Surgery, the doctor has led numerous national multicenter clinical trials and has authored over 120 peer-reviewed articles. The doctor is recognized as one of Spain's leading experts in genitourinary oncology.